Pharmacokinetics and Bioavailability of 2-Diethylamino-2′6′-Dimethylphenylacetamide L-Glutaminate
Rita M. Termulaeva(Chechen State University), Д. С. Блинов(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), Тимошкин Д.Е.(Sechenov University), Mahin Farahmand(Shiraz University of Medical Sciences), Екатерина Блинова(Sechenov University), Elena V. Semeleva(National Research Mordovia State University), Alexey A. Dmitriev(Engelhardt Institute of Molecular Biology), K. D. Blinov(Sechenov University), N. D. Bunyatyan(Belgorod National Research University), Alexander S. Pirozhkov(National Research Mordovia State University), S. Ya. Skachilova
Cited by 0
Related Papers
ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells
|Oxidative Medicine and Cellular Longevity|2019|895
LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms
|International Journal of Molecular Sciences|2020|230
Cancer Occurrence in Fars Province, Southern Iran
|Unknown|2008|97
Long Noncoding RNA GAS5 in Breast Cancer: Epigenetic Mechanisms and Biological Functions
|International Journal of Molecular Sciences|2021|94
Therapeutic Potential and Main Methods of Obtaining Selenium Nanoparticles
|International Journal of Molecular Sciences|2021|85